tirzepatide vs zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Weight-Loss Drug Zepbound Is Being

Just over 74% of participants in a clinical trial of semaglutidethe active ingredient in Ozempicexperienced mild, temporary side effects like nausea, vomiting, and constipation

Once youve reached your goal weight, well coach you on what to do in the long term to keep it off

At these doses, you should be working closely with your provider and monitoring for side effects

Methodology A poll of 1,073 American adults was conducted between February 19-23, 2026, using the AmeriSpeak Omnibus, a bi-monthly multi-client survey using the AmeriSpeak panel, NORCs probability-based panel that is designed to be representative of the U.S